Varithena® Foam Sclerosant


Varithena® lets you easily treat any vein shape and a wide range of sizes*.

  • GSV, AASV, PASV, and visible varicosities
  • Small, medium, and large diameters (including ≥12 mm)
  • Tortuous and recurrent
  • CEAP clinical class 2-6
  • 84% of patients had virtually no symptoms one year after treatment


Benefits of Varithena® 

  • No tumescent anesthesia and a virtually pain-free procedure
  • Cohesive, low-nitrogen microfoam goes where thermal can’t 16 MECHANISM OF ACTION >
  • Data demonstrates efficacy and durability of Varithena® treatment in the GSV EFFICACY >
  • Safety evaluated in 1333 patients in 12 clinical trials SAFETY PROFILE>
  • Support to help you integrate Varithena® into your practice
    • No capital equipment unique to Varithena® required
    • Dedicated CPT codes 36465 and 36466 REIMBURSEMENT >
 

Varithena®: Comprehensive* treatment for GSV system incompetence1,2

Varithena® (polidocanol injectable foam) is indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins and visible varicosities of the great saphenous vein (GSV) system. Varithena® improves the symptoms of superficial venous incompetence and the appearance of visible varicosities. CASE STUDIES >

 

If you would like materials to help tell your patients about Varithena® including patient brochures, posters, press release templates and web announcements, please Contact Us or discuss with your Varithena® Sales representative.

 

Mechanism of Action

 

Are you listed on our  Physician Finder?

                           
Varithena® treats a range of vein anatomies and diameters*
Contact Us
To Become a Varithena® Certified Doctor
Enter security code:
 Security code

CONTACT BOSTON SCIENTIFIC

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

This website is intended for visitors from the United States.